Tongjitang Chinese Medicines Company announced it has bought back 19.3 million shares of its stock from four institutional funds. The buyback represents 15% of Tongjitang’s outstanding shares, reducing the count of outstanding shares from 128.2 million to 108.9 million. The company said the average price paid was $4.10 per ADS (each ADS is equivalent to four ordinary shares). More details...

Stock Symbol: (NYSE: TCM)